Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • jpummil
    Member
    • Apr 2014
    • 85

    Canu sensitivity to genomeSize parameter

    I am currently working with some Bio faculty on a de novo assembly of Centruroides vittatus (Striped Bark Scorpion). One difficulty I seem to be having involves the command line parameter "genomeSize=" in Canu. Of course, one of the real difficulties with de novo is you likely don't know the size of the genome. You may not even have an estimate from a close relative species.

    I currently have two PacBio runs (different specimens in each) labeled Q1133 and Q1171. It seems that by varying the "genomeSize=" parameter, the output of the assembly can be significantly different! I am attaching a Quast output for some recent runs...two for each data set, with only the genomeSize parameter modified (genomeSize=170 and genomeSize=350).

    It seems that not many people have produced tools to estimate genome size in new projects that involve PacBio or ONT data...I did have some old Illumina data that was kind of iffy, but I tried the new GenomeScope tool from Schatz, et al and it comes up pretty consistently around 180Mb for an expected genome size. It was suggested to try the tool using the corrected reads out of Canu, but the tool doesn't seem to be able to evaluate that sort of input at this time.

    Any suggestions on how to best approach the problem (if it IS a problem and not simply an error on my part)? I am using essentially default values in Canu.
    Attached Files
  • rhall
    Senior Member
    • Aug 2012
    • 324

    #2
    Now that you have some contigs, why not map all your raw data to one of the assemblies and look at the coverage distribution across the contigs.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 11:41 AM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    34 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    44 views
    0 reactions
    Last Post SEQadmin2  
    Working...